Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Medical Bionic Implant/Artificial Organs Market By 2029?
The medical bionic implant and artificial organs sector has experienced substantial expansion lately, projected to increase from a valuation of $23.71 billion in 2024 to $25.22 billion in 2025, reflecting a compound annual growth rate of 6.3% during this period; this upward trajectory in the past is attributable to several factors, including a swelling elderly demographic, progress in the field of materials science, financial backing and encouragement from governmental bodies, broader societal acceptance of internal medical devices, alongside enhanced patient knowledge and educational outreach initiatives.
The sector dedicated to medical bionic implants and artificial organs anticipates substantial expansion in the coming years, with projections indicating its value will reach $34.38 billion by 2029, reflecting an 8.1% compound annual growth rate (CAGR) throughout the forecast duration; this upward trajectory is fueled by developments in tissue engineering and bioprinting technologies, the introduction of biohybrid implants, concentrated efforts in cardiac bionics, improvements to sensory feedback systems, and advances within regenerative medicine as applied to bionics; meanwhile, key shifts observed during this period encompass progression in prosthetic and orthotic devices, heightened attention toward brain-machine interfaces (BMIs), development of bionic organs intended for transplantation, utilization of 3D printing in creating bionic implants, deeper integration of artificial intelligence (AI) capabilities, and the incorporation of wireless connectivity alongside capabilities for remote oversight.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7870&type=smp
Which Drivers Are Impacting The Medical Bionic Implant/Artificial Organs Market?
Escalating instances of traffic collisions and resulting harm are anticipated to stimulate expansion within the medical bionic implant and artificial organ sector moving ahead. Injuries sustained due to vehicular incidents encompass any occurrence on a public roadway leading to harm for the affected individual. Replacements involving artificial organs and tissues are necessitated to correct physical damage often stemming from sudden, severe occurrences such as auto crashes, acts of violence, occupational mishaps, or complicated deliveries. Illustratively, data from the National Highway Traffic Safety Administration, a US governmental body dedicated to ensuring safe transit, indicated in May 2022 that fatalities from motor vehicle collisions saw a 10.5 percent jump, approximating 42,915 fatalities compared to the 38,824 recorded in the two preceding years. Consequently, the escalating frequency of injurious road accidents is serving as a catalyst for the advancement of the market for medical bionic implants and artificial organs.
How Is The Medical Bionic Implant/Artificial Organs Market Segmented?
The medical bionic implant/artificial organsmarket covered in this report is segmented –
1) By Type: Bionic Implants, Artificial Organs
2) By Method Of Fixation: Implantable, Externally Worn
3) By Technology: Electronic, Mechanical
4) By Application: Hospitals, Clinics, Research And Academic Institutes, Other Applications
Subsegments:
1) By Bionic Implants: Bionic Limbs, Bionic Eyes, Cochlear Implants, Artificial Organs
2) By Artificial Organs: Artificial Hearts, Artificial Kidneys, Artificial Livers, Artificial Pancreas
What Are The Major Trends Driving The Growth Of The Medical Bionic Implant/Artificial Organs Market?
A prominent and growing trend witnessed within the sphere of medical bionic implants and artificial organs involves the forging of strategic alliances, as numerous market participants are actively pursuing collaborations as a means to solidify their competitive standing. Illustratively, by September 2024, US manufacturer Beta Bionics entered into an agreement with US device firm Abbott Laboratories; this involved merging Beta Bionics’ iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 continuous glucose monitoring (CGM) apparatus, intending to significantly improve diabetes care for iLet users through direct incorporation of Abbott’s sophisticated CGM capabilities. Additionally, in February 2022, US research firm HUMOTECH, which focuses on artificial organs, established a relationship with the public research institution, the University of Michigan. The objective of this coupling is to fast-track the creation of control software for bionic legs, potentially bestowing prosthetic users with a walking motion and strength akin to that of a biological leg, with HUMOTECH undertaking the task of producing revised iterations of the open-source leg to support both prosthesis recipients and investigators within this venture.
Which Major Industry Participants Are Leading The Medical Bionic Implant/Artificial Organs Market Growth?
Major companies operating in the medical bionic implant/artificial organs market are Medtronic PLC, Boston Scientific Services Private Limited., Abbott Laboratories Inc., Zimmer Biomet Holdings Inc., Ekso Bionics Holdings Inc., Cochlear Limited, Cyberonics Inc., LivaNova PLC, NeuroPace Inc., Ossur India Private Limited, Vivani Medical Inc., St Jude Medical India Private Limited, LifeNet Health Inc., Ottobock SE & Co. KGaA, Edwards Lifesciences India Pvt. Ltd., SynCardia Systems LLC, Demant A/S, Berlin Heart GmbH, Conmed Devices Private Limited, Wright Medical Group N.V., Abiomed Inc., Baxter Laboratories Inc., Asahi Kasei Medical Co. Ltd., Getinge AB, Bornlife Prosthetic and Orthotic Inc., Sonova Holding AG, Biocontrol Medical Ltd., Orthofix International Inc., Aleva Neurotherapeutics SA, Second Sight Medical Products Inc., Touch Bionics Inc., Thoratec Corporation, CardiacAssist Inc., HeartWare International Inc., Synapse Biomedical Inc., Neurotech NA Inc., Retina Implant AG, Advanced Bionics AG, Med-El Elektromedizinische Geräte GmbH
Download The Full Report For Exclusive Market Findings:
How Is Medical Bionic Implant/Artificial Organs Market Demand Varying Across Different Regions?
Asia-Pacific was the largest region in the medical bionic implant/artificial organs market share in 2024. The regions covered in the medical bionic implant/artificial organs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Medical Bionic Implant/Artificial Organs Market Report:
https://www.thebusinessresearchcompany.com/customise?id=7870&type=smp
Browse Through More Reports Similar to the Global Medical Bionic Implant/Artificial Organs Market 2025, By The Business Research Company
Medical And Diagnostic Laboratory Services Global Market Report 2025
Medical Feed Additives Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-feed-additives-global-market-report
Medical Equipment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/medical-equipment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model